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Abstract
Background: Burkholderia cenocepacia is a Gram-negative opportunistic pathogen displaying high resistance to
antimicrobial peptides and polymyxins. We identified mechanisms of resistance by analyzing transcriptional
changes to polymyxin B treatment in three isogenic B. cenocepacia strains with diverse polymyxin B resistance
phenotypes: the polymyxin B-resistant parental strain K56-2, a polymyxin B-sensitive K56-2 mutant strain with
heptoseless lipopolysaccharide (LPS) (RSF34), and a derivative of RSF34 (RSF34 4000B) isolated through multiple
rounds of selection in polymyxin B that despite having a heptoseless LPS is highly polymyxin B-resistant.
Results: A heptoseless LPS mutant of B. cenocepacia was passaged through multiple rounds of selection to regain
high levels of polymyxin B-resistance. This process resulted in various phenotypic changes in the isolate that could
contribute to polymyxin B resistance and are consistent with LPS-independent changes in the outer membrane.
The transcriptional response of three B. cenocepacia strains to subinhibitory concentrations of polymyxin B was
analyzed using microarray analysis and validated by quantitative Real Time-PCR. There were numerous baseline
changes in expression between the three strains in the absence of polymyxin B. In both K56-2 and RSF34, similar
transcriptional changes upon treatment with polymyxin B were found and included upregulation of various genes
that may be involved in polymyxin B resistance and downregulation of genes required for the synthesis and
operation of flagella. This last result was validated phenotypically as both swimming and swarming motility were
impaired in the presence of polymyxin B. RSF34 4000B had altered the expression in a larger number of genes
upon treatment with polymyxin B than either K56-2 or RSF34, but the relative fold-changes in expression were
lower.
Conclusions: It is possible to generate polymyxin B-resistant isolates from polymyxin B-sensitive mutant strains of
B. cenocepacia, likely due to the multifactorial nature of polymyxin B resistance of this bacterium. Microarray
analysis showed that B. cenocepacia mounts multiple transcriptional responses following exposure to polymyxin B.
Polymyxin B-regulated genes identified in this study may be required for polymyxin B resistance, which must be
tested experimentally. Exposure to polymyxin B also decreases expression of flagellar genes resulting in reduced
swimming and swarming motility.
Background
Burkholderia cenocepacia belongs to the B. cepacia
complex (Bcc), a group of Gram-negative opportunistic
pathogens infecting patients with cystic fibrosis (CF)
and chronic granulomatous disease [1-3]. These infec-
tions are detrimental in CF patients because the bacteria
can spread between patients via social contact [4], and
in some cases patients develop an acute and fatal infec-
tion known as “cepacia syndrome” [2]. Treatment of Bcc
infections is difficult because the bacteria are resistant
to many antibiotics [5-7], including antimicrobial pep-
tides and polymyxins [8-11], a group of compounds that
have been proposed as potential new therapeutics for
treatment of Pseudomonas aeruginosa lung infections in
CF patients [12,13].
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crobial peptide resistance in B. cenocepacia [14] with the
first and most significant tier consisting of the complete
lipopolysaccharide (LPS) core oligosaccharide (OS) [9,15]
and the lipid A and core OS aminoarabinose residues that
are essential for the viability of B. cenocepacia [16,17]. This
tier accounts for the low binding of polymyxin B to B. ceno-
cepacia cells and poor permeabilization of the B. cenocepa-
cia outer membrane [10]. The second tier consists of other
mechanisms that each contribute a small amount of anti-
microbial peptide resistance but that as whole contribute
significantly to the high resistance of this organism [14].
Based on the observation that about 1% of polymyxin
B-sensitive B. cenocepacia heptoseless LPS mutant cells
survive treatment with 500 μg/ml of the antimicrobial
peptide polymyxin B for 24 hours (Loutet and Valvano,
unpublished), we hypothesized that B. cenocepacia hepto-
seless LPS isolates with increased resistance to polymyxin
B could be obtained. We cultured a polymyxin B-sensi-
tive B. cenocepacia heptoseless LPS mutant, RSF34 [18],
in a way that allowed for the isolation of clones with
increased resistance to polymyxin B to identify other
mechanisms of antimicrobial peptide resistance in this
highly resistant organism. RSF34 has a polymyxin B mini-
mum inhibitory concentration-50 (MIC50)o f3 2μg/ml
which is much lower than the full-length LPS strain from
which it was derived, K56-2, which has a polymyxin B
MIC50 of > 1024 μg/ml [14,18]. B. cenocepacia strains
with heptoseless LPS make an LPS molecule that consists
of lipid A and the innermost core oligosaccharide sugars:
a trisaccharide of 3-deoxy-D-manno-oct-2-ulopyranoso-
nic acid (Kdo), D-glycero-D-talo-oct-2-ulopyranosonic
acid (Ko) and 4-amino-4-deoxy-L-arabinose (L-Ara4N).
Our isolation procedure led to the generation of heptose-
less LPS strains with an increasing range of polymyxin B
resistance levels, some with at least 40-fold greater resis-
tance than RSF34. Next, we determined how B. cenocepa-
cia responds at the transcriptional level after treatment
with polymyxin B, as a strategy for identifying additional
mechanisms of antimicrobial peptide resistance in B. cen-
ocepacia. We used three strains for this study: K56-2, the
parental clinical isolate that is highly resistant to poly-
myxin B [19], RSF34, and RSF34 4000B, the isolate of
RSF34 selected for the highest level of polymyxin B resis-
tance. We established the baseline differences in tran-
scription between the strains in the absence of polymyxin
B challenge and identified genes transcriptionally regu-
lated by the presence of polymyxin B in the three strains.
Results
Isolation and characterization of polymyxin B-resistant B.
cenocepacia heptoseless LPS clones
Through sequential passage of the heptoseless LPS
mutant RSF34, clones were isolated with increasing
resistance to polymyxin B. Strain RSF34 25A was iso-
lated from a single colony of RSF34 that grew on LB
supplemented with 25 μg/ml polymyxin B. Strain RSF34
200E was isolated from a colony of RSF34 25A that
grew on LB with 200 μg/ml polymyxin B, strain RSF34
1000D was isolated as a colony of RSF34 200E that
grew on LB containing l000 μg/ml polymyxin B, and
strain RSF34 4000B was isolated as a colony of RSF34
1000D that grew on LB containing 4000 μg/ml poly-
myxin B (Table 1). At each stage of the selection pro-
cess, an isolate was chosen for the next stage of
selection using the following criteria: (1) maintenance of
the heptoseless LPS phenotype, (2) a demonstrable
increase in polymyxin B resistance using the polymyxin
B plate challenge and also, (3) if possible, a demon-
strable increase in polymyxin B resistance in the liquid
polymyxin B challenge. The number in the nomencla-
ture used for the isolates refers to the concentration of
polymyxin B on which the isolate was obtained (in μg/
ml); the letter distinguishes different isolates obtained
on the same concentration of polymyxin B. To obtain
highly polymyxin B-resistant RSF34 isolates required
multiple rounds of selection. When RSF34 was plated
directly on LB plates with 200 or 1000 μg/ml of poly-
myxin B no colonies were obtained.
The increased resistance after each round of selection
is demonstrated in Figure 1. All strains grew equally
well on LB plates with a vehicle control (top left). When
plated on LB with 25 μg/ml polymyxin B the growth of
RSF34 was significantly impaired (top right). The growth
of both RSF34 and RSF34 25A was significantly
impaired on LB with 200 μg/ml polymyxin B (bottom
left). Only K56-2, RSF34 1000D, and RSF34 4000B grew
on LB with 1 mg/ml polymyxin B, and RSF34 4000B
grew better than RSF34 1000D. No differences were
detected in the LPS profiles of any of the resistant iso-
lates (Additional file 1 Figure S1A) and all strains grew
similarly under standard laboratory conditions (Addi-
tional file 1 Figure S1B). The LPS phenotype could be
complemented in trans with a plasmid (pSL7) contain-
ing both the hldA and hldD genes (Additional file 1 Fig-
ure S1C), while a vector control (pSL6) did not affect
the LPS phenotype of any of the resistant isolates (Addi-
tional file 1 Figure S1D). Also, RSF34 carrying pSL7
regained polymyxin B resistance to similar levels as the
parental strain K56-2 (data not shown), similarly to pre-
viously published results with the heptoseless LPS
mutant SAL1 [9]. Both hldA and hldD,w h i c ha r ec o -
transcribed, encode proteins required for the synthesis
of heptose sugars that are incorporated into the LPS
core oligosaccharide [9] and the transcription of both
genes is defective in RSF34 [18]; therefore, complemen-
tation of the LPS phenotype in RSF34 and any strains
derived from RSF34 requires that both hldA and hldD
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jected to a more detailed chemical analysis to determine
if there were subtle changes to the LPS molecule that
were not detectable on an LPS gel; this LPS did not dif-
fer substantially from the typical B. cenocepacia lipid A-
inner core oligosaccharide [15,20] (Additional file 2 Fig-
ure S2 and data not shown). PCR analysis confirmed the
presence of the original RSF34 deletion in the poly-
myxin B-resistant isolates (data not shown).
Next, we tested whether or not the changes are stable
or lost in the absence of selective pressure. Cells pas-
saged for five days in the absence of polymyxin B grew
as well on plates containing polymyxin B as cells grown
only overnight in the absence of polymyxin B (Addi-
tional file 3 Figure S3). From this we concluded that the
changes that have occurred in our polymyxin B-resistant
RSF34 isolates are likely constitutive.
Binding of polymyxin B was assayed using the fluores-
cent analogue, dansyl-polymyxin B. When bound to LPS
on whole cells, dansyl-polymyxin B will fluoresce at 485
nm after excitation at 340 nm. As previously demonstrated
[10,15], we detected high binding of dansyl-polymyxin B
to the positive control, P. aeruginosa strain PAO1, low
binding to B. cenocepacia strain K56-2, and a moderate
increase in binding to B. cenocepacia strain RSF34 (Figure
2A). This increase was similar to that found previously in
B. cenocepacia mutants with heptoseless LPS [15]. All of
the polymyxin B-resistant RSF34 isolates bound dansyl-
polymyxin B similarly to RSF34 (Figure 2A), indicating
that the levels of dansyl-polymyxin B binding in these
mutants are due to the heptoseless LPS and that increased
polymyxin B resistance in these mutants is not due to
decreased polymyxin B binding.
To measure cell envelope permeability, bacteria were
treated with 1-N-phenylnaphthylamine (NPN). In a
hydrophobic environment and excited at 350 nm, NPN
will emit at 420 nm. When treated with NPN, RSF34
emitted at 420 nm at about twice the level as K56-2
(Figure 2B). The polymyxin B-resistant RSF34 isolates
had decreased permeability to NPN compared to RSF34,
with the permeability of RSF34 strains 200E, 1000D, and
4000B roughly 30% less than RSF34 (Figure 2B, p-values
between 0.006 and 0.05). None of the polymyxin B-
resistant isolates had permeability reduced to the level
of the wild-type LPS strain K56-2 (Figure 2B). The
decreased permeability of the polymyxin B-resistant
RSF34 strains, suggest LPS-independent changes in the
outer membrane of these mutants leading at least in
part to increased polymyxin B resistance.
Consistent with this conclusion, changes in colony
morphology were also noted: K56-2 colonies are round
with smooth margins (Additional file 4 Figure S4), while
t h o s eo fR S F 3 4a r ei r r e g u l a r l ys h a p e d ,h a v ei r r e g u l a r
margins and appear to have the dry and brittle morphol-
ogy described as “crunchy” by Parker et al [21]. The col-
ony morphology of RSF34 25A is similar to RSF34, but
RSF34 200E, RSF34 1000D, and RSF34 4000B all form
colonies that are more similar to those of K56-2 (Addi-
tional file 4 Figure S4). Although the causes of these
changes are unknown, they are likely independent of the
presence of heptoseless LPS, which is common to all
mutant strains.
Together, these results indicate that the selection pro-
cess provided a series of clonal isolates with: (i) increas-
ing polymyxin B resistance, (ii) a stable polymyxin B
resistance phenotype, (iii) no detectable changes in the
Table 1 Strains and plasmids used in this study
Strain or Plasmid Description Source or Reference
Escherichia coli
DH5a F
-, j80 lacZ ΔM15 Δ(lacZYA-argF) U169 deoR endA1 recA1 hsdR17 (rK
- mK
+) thi-1 glnV44 Laboratory Stock
Burkholderia cenocepacia
K56-2 CF clinical isolate (polymxyin B-resistant) BCCRC*, [19]
RSF34 K56-2, ΔhldA (polymyxin B-sensitive) [18]
RSF34 25A RSF34 colony isolated on 25 μg/ml polymyxin B This study
RSF34 200E RSF34 25A colony isolated on 200 μg/ml polymyxin B This study
RSF34 1000D RSF34 200E colony isolated on 1 mg/ml polymyxin B This study
RSF34 4000B RSF34, selected through multiple rounds for polymyxin B resistance This study
RSF44 K56-2, ΔfliCD, flagella-negative [18]
Pseudomonas aeruginosa
PAO1 Non-CF clinical isolate [56]
Plasmids
pRK2013 RK2 derivative, Km
R mob
+ tra
+ oricolE1 [49]
pSL6 B. cenocepacia expression plasmid, rhamnose-inducible promoter, Tp
R Cm
R [9]
pSL7 pSL6, B. cenocepacia hldAD [9]
*B. cepacia complex Research and Referral Repository for Canadian CF Clinics
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Page 3 of 17original heptoseless LPS structure of RSF34, (iv) no sig-
nificant changes to bacterial fitness, (v) no decreased
polymyxin B binding to whole cells, (vi) some decrease
in membrane permeability, and (vii) a return to the col-
ony morphology of the parental K56-2 strain. The
absence of changes in LPS structure in the RSF34 4000B
mutant, suggests additional LPS-independent mechan-
isms of resistance most likely targeting the bacterial
outer membrane.
RSF34 1000D and RSF34 4000B have increased adherent
growth in the presence of high concentrations of
polymyxin B
Similar polymyxin B resistance results were also
obtained when the strains were challenged with poly-
myxin B in liquid culture (Figure 3A). With each round
of selection the resistant isolates grew better when chal-
lenged in liquid culture up to RSF34 1000D and RSF34
4000B which grew similarly in this assay (Figure 3A).
Figure 1 The resistance of B. cenocepacia RSF34 to polymyxin B increases with each round of selection. Shown is a representative image
of three independent experiments, neat is equal to an OD600 of 1.0.
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polymxyin B, both in liquid media and on solid media
was still considerably better than any of the resistant
R S F 3 4i s o l a t e s( F i g u r e1a n d3 A ) .I nl i q u i dc u l t u r ea t
high concentrations of polymyxin B (≥ 600 μg/ml), sig-
nificant amounts of the RSF34 1000D and RSF34 4000B
growth was either adherent to the sides of tubes or as
small microcolonies suspended in the media. Data in
Figure 3A represent the optical densities of the media
after resuspension of this adherent growth. To quantify
this observation, the experiments were repeated for
K56-2, RSF34, RSF34 1000D, and RSF34 4000B in the
presence of the vehicle control and either 25 μg/ml
polymyxin B (RSF34 only) or 600 μg/ml polymyxin B
(all other strains). After incubation the OD600 was mea-
sured from the culture before vortexing tubes and after
vortexing tubes. The OD600 did not change significantly
in K56-2 after vortexing regardless of treatment condi-
tion, for RSF34 the OD600 increased by about 25% after
vortexing, again regardless of treatment condition (Fig-
ure 4). This is consistent with the observation of
increased cell-to-cell interactions in other Gram-nega-
tive bacteria with truncated LPS molecules [22,23]. For
RSF34 1000D and RSF34 4000B grown in the presence
of the vehicle control there were increases in OD600
after vortexing similar to what is seen in RSF34 (Figure
4). However, in the presence of 600 μg/ml polymyxin B,
the OD600 values after vortexing were 6.9-fold and 5.4-
fold greater than before vortexing for RSF34 1000D and
RSF34 4000B, respectively (Figure 4).
Increased resistance is neither specific to polymyxin B nor
a general phenomenon
The polymyxin B-resistant isolates were tested for
increased resistance to honey bee melittin, an
Figure 2 Dansyl-polymyxin B binding to (A) and 1-N-phenylnaphthylamine permeability of (B) polymyxin B-resistant RSF34 isolates.
(A) Shown are the means and standard error of the means for three experiments, each done in duplicate. P-values for unpaired, Student’st -
tests; ns, no significant difference. (B) Shown are the means and standard error of the means for five experiments, each done in duplicate. P-
values for unpaired, Student’s t-tests.
Figure 3 Polymyxin B-resistant RSF34 isolates have increased
polymyxin B resistance in liquid culture and some increase in
resistance to melittin. Growth of K56-2 (red), RSF34 (blue), RSF34
25A (green), RSF34 200E (black), RSF34 1000D (purple), and RSF34
4000B (brown) in liquid culture with between 0 and 1000 μg/ml of
polymyxin B (A) or 0 and 200 μg/ml of melittin (B). Data shown are
the means for four (polymyxin B) or five (melittin) independent
experiments; error bars represent the standard error of the mean.
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myxin B. There were modest increases in melittin resis-
tance in RSF34 200E, RSF34 1000D, and RSF34 4000B (all
of which grew similarly in melittin), but the growth of all
of the heptoseless LPS isolates was inhibited by at least
75% in 200 μg/ml melittin (Figure 3B).
Disk diffusion assays were used to test for increased resis-
tance of the polymyxin B-resistant clones to non-peptide
antimicrobial compounds and the results are shown in
Table 2. No substantial increases in resistance to SDS, novo-
biocin, tetracycline, or chloramphenicol were seen in any of
the polymyxin B-resistant isolates compared to the original
heptoseless mutant RSF34. Polymyxin B-resistant isolates
RSF34 200E, RSF34 1000D, and RSF34 4000B were all more
resistant to imipenem than RSF34 with the latter two strains
exhibiting resistance to imipenem similar to the wild-type
LPS strain K56-2. Additionally, RSF34 4000B demonstrated
increased resistance to gentamicin compared to RSF34 and
the other polymyxin B-resistant isolates. Disks spotted with
the vehicles in which these antimicrobial compounds were
dissolved (water and 95% ethanol) did not impair the growth
of any of the strains. Together, these results indicate that the
increased resistance to polymyxin B seen in these RSF34 iso-
lates is not completely specific to polymyxin B since they
demonstrate some increased resistance to a second antimi-
crobial peptide as well as some non-peptide antimicrobials,
but that the increased resistance is not a general phenom-
enon since the polymyxin B-resistant isolates are as sensitive
as RSF34 to many antimicrobial agents.
Experimental approach for microarray analysis
To obtain a comprehensive view of the transcriptional
response of B. cenocepacia to polymyxin B, and to gain
greater insight into the changes that have occurred
through our selection process, microarray analysis was
conducted on the transcriptional response to treatment
with sub-inhibitory concentrations of polymyxin B in
three strains (K56-2, RSF34, and RSF34 4000B). For each
of the strains we compared transcription in the presence
of polymyxin B to transcription in the presence of a vehi-
cle control. Additionally, to obtain baseline differences
between the strains we also compared transcription in
t h ep r e s e n c eo ft h ev e h i c l ec o n t r o lb e t w e e nK 5 6 - 2a n d
RSF34, and between RSF34 and RSF34 4000B. Concen-
trations of polymxyin B used in these studies were 25 μg/
ml for RSF34 and 500 μg/ml for K56-2 and RSF34 4000B.
These were the highest concentrations tested that did not
inhibit growth of the strains under the conditions
described in the methods (data not shown).
Establishment of baseline differences between K56-2,
RSF34, and RSF34 4000B
Before analyzing the transcriptional responses in the
presence of polymyxin B in the three strains used in this
Figure 4 RSF34 1000D and RSF34 4000B growth in high
concentrations of polymyxin B is mainly as microcolonies
resuspended in the media or adhered to Eppendorf tube walls.
Cells were grown for 24 hours in either the vehicle control or
polymyxin B (25 μg/ml for RSF34 or 600 μg/ml for all other strains).
The OD600 was measured before vortexing and after vortexing (to
resuspend microcolonies and growth that was adherent to tube
walls). Shown are the means of the ratios of OD600 values post-
vortex to pre-vortex for three experiments, with each experiment
done in duplicate. Error bars represent the standard errors of the
mean. *, Statistically significant difference (p < 0.01) between ratios
for growth in the presence of the vehicle control and growth in
polymyxin B by unpaired student’s t-test.
Table 2 Disk diffusion assay results
Zone of inhibition (mm)*
Strain SDS Novobiocin Tetracycline Gentamicin Chloramphenicol Imipenem
K56-2 11.3 ± 0.4 22.0 ± 0.4 17.3 ± 1.1 18.6 ± 0.6 17.4 ± 0.3 15.6 ± 0.1
RSF34 21.1 ± 0.3 27.2 ± 0.5 16.8 ± 1.4 20.6 ± 0.1 18.3 ± 0.5 36.7 ± 0.7
RSF34 25A 17.9 ± 0.6 29.3 ± 0.2 17.0 ± 0.7 23.8 ± 0.6 18.2 ± 0.8 35.9 ± 0.5
RSF34 200E 17.8 ± 0.4 30.0 ± 0.4 17.9 ± 0.9 22.7 ± 0.8 19.4 ± 0.1 25.9 ± 1.3
RSF34 1000D 18.3 ± 0.8 30.0 ± 0.4 16.1 ± 1.6 21.2 ± 0.5 19.3 ± 0.5 18.2 ± 0.8
RSF34 4000B 19.9 ± 0.5 29.8 ± 0.3 17.2 ± 1.6 14.2 ± 1.1 20.0 ± 0.5 17.1 ± 0.8
* Values presented are the means and standard error of the means for three or four experiments done in triplicate.
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transcription between the strains under the conditions
tested in this study. Genes differentially regulated in the
presence of the vehicle control between K56-2 and
RSF34 are listed in Sheet 1 of Additional file 5 Table S1,
while genes differentially regulated in the presence of
the vehicle control between RSF34 and RSF34 4000B
are listed in Sheet 2 of Additional file 5 Table S1. Genes
differentially regulated between the strains were sepa-
rated into functional classes based on their COG desig-
nations (Figure 5). Some interesting patterns of
expression were seen when comparing baseline levels of
expression in the three strains. Various genes were sig-
nificantly overexpressed in RSF34 compared to K56-2
(some by over 50-fold) and were also significantly down-
regulated in RSF34 4000B compared to RSF34
Figure 5 COG designations of genes differentially regulated under baseline conditions for K56-2, RSF34, and RSF34 4000B. Genes up-
or down-regulated by two-fold or more under vehicle control conditions between RSF34 and K56-2 (blue bars) and RSF34 4000B and RSF34
(red bars) were grouped according to the designations given to their corresponding proteins in the Clusters of Orthologous Groups Database
[28] and the Burkholderia Genome Database [27].
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genes spanning from BCAM0529 to BCAM0538 that are
predicted to encode proteins with a variety of functions,
a cluster of genes spanning from BCAM0854 to
BCAM0864 and known to be involved in biosynthesis of
the exopolysaccharide cepacian [24,25], and BCAM2453
which is a monocistronic gene that is predicted to
encode a protein with redoxin activity. Representative
genes from these clusters, BCAM0537, BCAM0855,a n d
BCAM2453, were selected for transcriptional analysis by
quantitative Real Time-PCR (qRT-PCR). The patterns of
expression for these genes demonstrated by microarray
analysis were confirmed by qRT-PCR (Table 3).
Other genes significantly overexpressed in RSF34 com-
pared to K56-2 that are not then altered between RSF34
4000B and RSF34 include many genes predicted to
encode exported proteins, lipoproteins, as well as pro-
teins involved in cell envelope biogenesis, carbohydrate
transport and metabolism, an efflux system, and a lectin
(Additional file 5 Table S1). BCAL3490, BCAM0083,
BCAM0186, and BCAM1010 were chosen as representa-
tive up-regulated genes and this was confirmed by qRT-
PCR (Table 3).
There were few genes downregulated to a large extent
in RSF34 compared to K56-2 (Additional file 5 Table
S1). The gene BCAL2945 shown in Additional file 5
Table S1 to be down-regulated 87.4-fold in RSF34 com-
pared to K56-2 is hldA,t h eg e n ed e l e t e di nR S F 3 4 .
Otherwise the only other gene down-regulated by 5-fold
or more in RSF34 is BCAL0114 that encodes flagellin.
This is consistent with the observation that RSF34 is
less motile than K56-2 (Additional file 6 Figure S5);
Table 3 Real-time PCR validation of selected genes identified by microarray analysis as differentially regulated
Gene (predicted function of encoded protein) Fold-Change
Microarray
a Real-Time PCR
b
Genes differentially regulated in RSF34 compared to K56-2
BCAL0114 (Flagellin) -5.8 No change
BCAL3490 (Exported protein) 12.0 6.8
BCAM0083 (Hypothetical protein) 12.1 10.0
BCAM0186 (Lectin) 14.4 9.8
BCAM0537 (Serine peptidase) 51.0 8.0
BCAM0855 (UDP-glucose dehydrogenase) 22.2 13.5
BCAM1010 (putative UTP-glucose-1-phosphate) 15.2 20.7
BCAM2453 (Redoxin) 40.5 6.2
Genes differentially regulated in RSF34 4000B compared to RSF34
BCAL1083 (Exported alkaline phosphatase) -16.7 -3.2
BCAL1213 (2-oxoisovalerate dehydrogenase b subunit) 29.9 19.7
BCAL1270 (Phosphate transport, periplasmic) -23.5 -17.9
BCAM0537 (Serine peptidase) -28.2 -4.1
BCAM0855 (UDP-glucose dehydrogenase) -5.0 -4.2
BCAM2195 (AMP-binding enzyme) 22.8 4.9
BCAM2453 (Redoxin) -22.5 -1.9
Genes differentially regulated in K56-2 upon polymyxin B treatment
BCAL0114 (Flagellin, FliC) -4.9 -10.3
BCAL0140 (Flagellar biosynthesis) -25.9 -26.2
BCAL0520 (Flagellar hook-length control, FlhB) -15.1 -131.9
BCAL0566 (Flagellar basal body rod modification, FlgD) -17.1 -7.7
BCAL1351 (Exported Protein) 3.6 31.3
BCAL3507 (FliL) -13.6 -4.3
BCAM0083 (Hypothetical protein) 21.4 34.5
BCAM2187 (Macrolide-specific ABC-type efflux) 9.5 33.7
aData shown are the mean from three independent experiments.
bData shown are the mean of two or three independent experiments, which are also independent of those used for microarray analysis.
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expression between RSF34 and K56-2 (Table 3). All
other genes are downregulated by 4-fold or less and
more than 50% of these genes were predicted prophage-
related genes in the genomic island BcenGI12, which
spans from BCAM1024 to BCAM1096 [26,27]. Again,
there is reciprocal regulation of the genes in BcenGI12
and they are upregulated in RSF34 4000B compared to
RSF34 (Additional file 5 Table S1).
Finally there were genes differentially expressed in
RSF34 4000B compared to RSF34 that were not signifi-
cantly altered between RSF34 and K56-2 (Additional file
5 Table S1). These genes include two clusters
(BCAL1212 to BCAL1215 and BCAM2191 to
BCAM2196)t h a ta r eo v e r e x p r e s s e db y1 0 - f o l do rm o r e
and are predicted to encode proteins involved in energy
production and lipid metabolism. Genes down-regulated
by 10-fold or more include one cluster (BCAL1270 to
BCAL1276) predicted to encode a phosphate ABC trans-
port system and BCAL1083, which encodes a predicted
exported alkaline phosphatase. qRT-PCR analysis of
representative genes from these clusters (BCAL1213,
BCAL2195, BCAL1270, and BCAL1083) confirmed these
patterns of expression (Table 3). These genes are of
interest because their changes in expression could con-
tribute to the increased resistance of RSF34 4000B to
polymyxin B compared to RSF34. With the baseline dif-
ferences between K56-2, RSF34, and RSF34 4000B
established, we next sought to investigate the polymyxin
B transcriptional responses made by each of these three
strains.
Cell motility associated genes are downregulated by B.
cenocepacia K56-2 upon polymyxin B treatment
B. cenocepacia K56-2 was grown to mid-log phase, trea-
ted with 500 μg/ml of polymyxin B or a vehicle control,
RNA was extracted, converted to cDNA, and subjected
to microarray analysis. For a complete list of genes dif-
ferentially regulated in the presence of polymyxin B
compared to the vehicle control in K56-2 see Sheet 1 of
Additional file 7 Table S2. The differentially regulated
genes were organized according to their Clusters of
Orthologous Groups (COG) designations (Figure 6)
[28]. The largest group of differentially regulated genes
was those associated with cell motility. Almost all genes
encoding proteins required for building and operating
flagella are divided into five clusters located on the lar-
gest chromosome of B. cenocepacia (BCAL0113-
Figure 6 COG designations of genes differentially regulated upon treatment with polymxyin B in K56-2. Genes up- or down-regulated
by two-fold or more upon treatment with polymyxin B compared to treatment with the vehicle control were grouped according to the
designations given to their corresponding proteins in the Clusters of Orthologous Groups Database [28] and the Burkholderia Genome Database
[27].
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BCAL0527, BCAL0561-BCAL0577, BCAL3501-
BCAL3507) [26]. Genes from all five of these clusters
were downregulated upon treatment with polymxyin B
(Additional file 7 Table S2). Furthermore, the only
genes differentially downregulated by 10-fold or more in
the presence of polymyxin B were genes in these clus-
ters. Downregulation was confirmed by qRT-PCR (Table
3) for one gene from each of the five clusters
(BCAL0114, BCAL0140, BCAL0520, BCAL0566,a n d
BCAL3507). Based on these results we concluded that
under the conditions we tested, one of the major tran-
scriptional responses of B. cenocepacia to polymyxin B
was a downregulation of cell motility genes, particularly
those required for flagella. Two assays were conducted
to test for a role for flagella in polymyxin B resistance.
First, MIC50 values were determined for B. cenocepacia
strain K56-2 and an isogenic, non-flagellated mutant,
RSF44 [18]. Both strains had MIC50 values greater than
1024 μg/ml for polymyxin B, which was the highest con-
centration tested. Second, bacteria were grown overnight
in liquid culture and then serial dilutions were plated on
s o l i da g a rp l a t e sc o n t a i n i n ge i t h e r5 0 0μg/ml polymyxin
B or a vehicle control. Both strains grew equally well
under either of the conditions (data not shown).
Together, these experiments suggested that a mutant
that lacks flagella maintains polymyxin B resistance at
least at the concentrations tested and that the concen-
trations of polymyxin B tested in the following assays do
not significantly inhibit the growth of either of the
strains.
Swimming and swarming motility are impaired by
polymyxin B
Of the five types of bacterial motility that have been
described (swimming, swarming, twitching, gliding, and
sliding) [29], two, swimming and swarming, are depen-
dent on flagella [30] and have been demonstrated to
occur in B. cenocepacia [31,32]. We tested the effect of
polymyxin B on the ability of B. cenocepacia to move by
both of these mechanisms. The parental strain K56-2
and a flagella-negative mutant, RSF44, were inoculated
into semi-solid agar plates containing either a vehicle
control or 500 μg/ml of polymyxin B throughout the
media to test for swimming motility. Growth of K56-2
in plates with the vehicle control radiated outwards
from the point of inoculation to a much greater extent
than it did in plates containing 500 μg/ml polymyxin B
(Figure 7A and 7B), while RSF44 grew as a single colony
at the point of inoculation regardless of treatment con-
dition (Figure 7A and 7B). Quantitation of this pheno-
type (Figure 7C) showed that on average the zone of
growth of K56-2 in swimming motility plates with the
vehicle control was more than twice the size of the
growth in plates with polymyxin B.
Assays were also conducted to determine if swarming
motility is impaired by polymyxin B. K56-2 was able to
swarm across plates containing the vehicle control (Fig-
ure 7D and 7F). The flagella-negative mutant RSF44
also grew across the surface of the plates with the vehi-
cle control, although to a much less extent than K56-2
(Figure 7D and 7F). Motility of both of these strains was
highly impaired in the presence of 500 μg/ml polymyxin
Figure 7 Swimming and swarming motility are inhibited in the presence of polymyxin B. Bacteria were inoculated into swimming motility
plates (A and B) or on swarming motility plates (D and E) containing either the vehicle control (A and D) or 500 μg/ml polymyxin B (B and E).
Images shown are representatives from six independent experiments. Diameters across the zones of bacterial swimming or swarming were
measured and the means and standard errors of the means for all six independent experiments are shown in (C and F). *Statistically significant
difference, p < 0.01 by student’s t-test between vehicle control and polymyxin B treatments.
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absence of polymyxin B for RSF44 are similar to those
reported for a Pseudomonas aeruginosa mutant lacking
both flagella and the type IV pili, which began to
undergo sliding motility when grown under conditions
required for swarming motility [33]. The authors of this
study also found that sliding and swarming motility
resulted from similar environmental cues, which could
explain why both K56-2 and RSF44 appear non-motile
in the presence of polymyxin B. These types of analyses
were not completed for RSF34 and RSF34 4000B
because both strains have motility similar to RSF44 in
the absence of polymyxin B (Additional file 6 Figure S5).
Polymyxin B treatment upregulates genes with diverse
functions
Treatment of K56-2 with polymyxin B led to the upre-
gulation of thirty genes (Sheet 1 of Additional file 7
Table S2), predicted to encode proteins involved in a
variety of pathways, particularly lipid transport and
metabolism and cell envelope biogenesis (Figure 6).
Genes that were amongst the most highly overexpressed
include: a cluster spanning BCAM0082 to BCAM0084
that contains genes encoding proteins with predicted
sugar modifying and transferase activities, BCAM1364,
encoding a predicted NAD dependent epimerase/dehy-
dratase, and BCAM2186 to BCAM2188, encoding a pre-
dicted macrolide efflux system. qRT-PCR conducted for
BCAM0083 and BCAM2187 demonstrated that both
genes were overexpressed (Table 3). qRT-PCR experi-
ments were also attempted for BCAM1364.H o w e v e r ,
these experiments failed, as we could not obtain a pri-
mer pair that efficiently amplified the transcript or the
gene from genomic DNA (data not shown). The genes
upregulated upon treatment with polymyxin B are of
interest as they may represent novel genes involved in
the resistance of B. cenocepacia to polymyxin B.
Regulation by polymyxin B in RSF34 and RSF34 4000B
Since we have previously identified genes involved in
polymyxin B resistance in RSF34 [14], we thought that
it might be possible to identify additional polymyxin B-
responsive genes in this strain that were not identified
in K56-2. In total, 59 genes were upregulated in RSF34
upon polymyxin B treatment (Sheet 2 of Additional file
7T a b l eS 2 )a n do ft h e3 0g e n e su p r e g u l a t e db yK 5 6 - 2
in the presence of polymyxin B, more than a third
appeared in the RSF34 data set as well. Of the remain-
ing 48 genes upregulated in RSF34 in the presence of
polymyxin B only two are upregulated by five-fold or
more. The only cluster that stood out in this data set
was a group of genes, BCAL1349 to BCAL1351,p r e -
dicted to encode a two-component regulatory system
and an outer membrane protein, transcribed in opposite
orientations. This cluster is also upregulated in K56-2 in
the presence of polymyxin B but not to the same extent
(less than four-fold). qRT-PCR experiments for
BCAL1351 using RNA extracted from K56-2 grown in
the presence or absence of polymyxin B indicated that
this cluster of genes is upregulated in the presence of
polymyxin B (Table 3). Almost all genes downregulated
by RSF34 in the presence of polymyxin B are involved
in the assembly or function of the flagellum (Sheet 2 of
Additional file 7 Table S2).
The picture is quite different in RSF34 4000B; 204
genes were found to be upregulated in the presence of
polymyxin B, all of which were upregulated by less than
five-fold (Sheet 3 of Additional file 7 Table S2). This list
of genes did not include some of the largest changes
described above, including the cluster spanning
BCAM0082 to BCAM0084, or the fold-changes were
less than those seen in K56-2 and/or RSF34. Only 32
genes were downregulated by RSF34 4000B in the pre-
sence of polymyxin B, a third of which were tRNA-
encoding genes, and none of which were flagellar-related
genes (Sheet 3 of Additional file 7 Table S2).
Discussion
Two genomic approaches were utilized to study poly-
myxin B resistance in B. cenocepacia.Al i n e a g eo f
increasingly polymyxin B-resistant heptoseless LPS
mutants was obtained through selection of resistant iso-
lates on media that prohibited the replication of the vast
majority of the cells plated. At each round of selection
approximately one polymyxin B-resistant isolate per 10
5
CFU plated was obtained. Initial characterization of
these isolates shows that they exhibited: (i) increased
polymyxin B resistance that is relatively stable, since it is
maintained after the cells are grown in the absence of
polymyxin B for five days; (ii) no defects in growth rate,
suggesting that the mutation or mutations do not affect
the general fitness of the bacteria, and (iii) increased
polymyxin B resistance in liquid media despite the fact
that selection of the isolates occurred on solid media.
These isolates show significant increases in resistance to
imipenem and melittin, and in the case of the final iso-
late (RSF34 4000B), to gentamicin.
Although it must be noted that the pleiotropic
changes seen in the polymyxin B-resistant isolates may
not all contribute to the polymxyin B resistance of the
isolates, many of the phenotypic changes seen in the
isolates could be associated with increased antimicrobial
peptide resistance. Subpopulations of P. aeruginosa and
E. coli within biofilms [34,35] have been shown to
develop increased antimicrobial peptide resistance and
the results presented here suggest that high concentra-
tions of polymyxin B induce increased adherent growth
of RSF34 1000D and RSF34 4000B, possibly resulting in
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from polymyxin B. The heptoseless LPS phenotype
induces outer membrane instability that has pleiotropic
effects on bacteria [36,37] including changes in colony
morphology changes [21,38,39]. The return to the wild-
type colony morphology in RSF34 200E and later iso-
lates could indicate that the polymyxin B-resistant iso-
lates may have altered outer membrane properties that
in some way stabilize the outer membrane. This inter-
pretation is consistent with our observation of decreased
NPN access to the outer membrane in the polymyxin B-
resistant isolates. Experiments are currently underway to
precisely determine the genes and/or proteins whose
expression and/or function have been altered through
the selection process to increase the polymyxin B resis-
tance of RSF34.
Microarray analysis conducted to compare baseline
changes in the gene expression between K56-2, RSF34
and RSF34 4000B show that there are many genes
whose expression are substantially upregulated in RSF34
compared to K56-2 (Additional file 5 Table S1, and
T a b l e3 ) .T h et y p e so fg e n e sd i f f e r e n t i a l l ye x p r e s s e di n
RSF34 compared to K56-2 are consistent with observa-
tions in the literature that heptoseless LPS mutants tend
to alter the synthesis of other polysaccharides [21,38,39],
The data are also similar to a microarray study of a Sal-
monella enterica serovar Typhimurium heptoseless LPS
mutant which showed changes in sugar metabolism and
expression of genes predicted to encode outer mem-
brane proteins and lipoproteins, as well as decreased
expression of genes required for the flagellum [40].
These types of changes are likely the consequence of the
pleiotropic effects seen in heptoseless LPS mutants
[36,37]. Interestingly, RSF34 4000B reverses some but
not all of these changes (Additional file 5 Table S1, and
Table 3). This is similar to some of the phenotypic
changes seen in this strain such as return to wild-type
colony morphology (Additional file 4 Figure S4) and
intermediate permeability to NPN (Figure 2B). Since
some of the genes overexpressed in RSF34 are downre-
gulated in RSF34 4000B, this isolate could have an
altered cell envelope that decreases these pleiotropic
effects, and also makes it less susceptible to polymyxin
B challenge. There are also genes (BCAL1212 to
BCAL1215, BCAM2191 to BCAM2196, BCAL1270 to
BCAL1276,a n dBCAL1083) whose expression is signifi-
cantly altered in RSF34 4000B compared to RSF34 but
are not altered between K56-2 and RSF34. These
c h a n g e si ng e n ee x p r e s s i o nm a yc o n t r i b u t et ot h e
increased polymyxin B resistance in RSF34 4000B,
which we are currently studying using mutagenesis
strategies.
Downregulation of motility-associated gene expression
is a major transcriptional response in B. cenocepacia
upon treatment with polymyxin B under the conditions
tested in this study which results in impairment of
swimming and swarming motility in the presence of
polymyxin B. None of the genes that have previously
been implicated in the resistance of B. cenocepacia to
antimicrobial peptides [9,14-16,41] were differentially
regulated by polymyxin B under the conditions tested. It
is possible that other conditions (such as higher concen-
trations of polymyxin B or treatment with other antimi-
crobial peptides) are required to see differential
regulation of these genes. It is also just as possible that
expression of these antimicrobial peptide resistance
genes are not regulated by the presence of antimicrobial
peptides in the environment and that major resistance
mechanisms are constitutively active in B. cenocepacia,
which could help to explain in part the high resistance
of B. cenocepacia to these compounds. There are var-
ious genes upregulated by both K56-2 and RSF34 grown
in the presence of polymyxin B, including genes encod-
ing proteins involved in lipid transport and metabolism,
cell envelope biogenesis, signal transduction, and tran-
scription, as well as genes of unknown function. Charac-
terization of potential roles in polymyxin B resistance
for these genes is currently underway.
At least two microarray studies have been published
on P. aeruginosa and its response to antimicrobial pep-
tides that have identified differential regulation of genes
associated with motility. Cummins et al showed that
exposure of planktonic cells to subinhibitory concentra-
tions of colistin (polymyxin E) lead to small decreases in
expression of genes associated with motility [42]. The
authors of this study also found that the response of P.
aeruginosa to colistin included upregulation of both
known colistin resistance genes as well as genes that
had not previously been shown to be involved in resis-
tance (such as genes involved in quorum sensing and
biofilm formation). Meanwhile, Overhage et al showed
that exposure of P. aeruginosa grown as biofilms in the
presence of subinhibitory concentrations of LL-37 led to
increased expression of type IV pili genes and decreased
expression of flagella genes [43]. Phenotypically, the pre-
sence of subinhibitory concentrations of LL-37 led to
increased twitching motility (which requires pili [30]),
but had no effect on swarming or swimming motility.
Swarming motility is a multicellular bacterial lifestyle
[30] and there are conflicting reports in the literature as
to whether or not this protects bacteria from antimicro-
bial peptides. Lai and colleagues [44] showed that
swarming cells of Escherichia coli, P. aeruginosa,a n d
Bacillus subtilis were more resistant than planktonic
cells to numerous antibiotics, except for the antimicro-
bial peptides polymyxin B and colistin; while Kim et al
[45] showed that swarming Salmonella enterica serovar
Typhimurium cells were more resistant than planktonic
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that a subinhibitory concentration of polymyxin B
greatly impairs the ability of B. cenocepacia to both
swim and swarm.
Conclusions
We demonstrate that it is possible to obtain heptoseless
LPS strains of B. cenocepacia with high resistance to
polymyxin B, and suggest that this may occur through
LPS-independent changes that stabilize the outer mem-
brane in some way. Furthermore, our data demonstrate
that major transcriptional changes made by B. cenocepa-
cia upon treatment with polymxyin B include downre-
gulation of genes required for the synthesis and
operation of the flagella and upregulation of a set of
genes encoding proteins with diverse predicted func-
tions. The contribution made by genes that are upregu-
lated by B. cenocepacia upon treatment with polymyxin
B to polymyxin B resistance must now be determined
and is underway in the Valvano Laboratory. Decreased
flagellar gene expression upon treatment with polymyxin
B impairs both swimming and swarming motility, two
processes that require the flagella. B. cenocepacia
mutants lacking flagella have been shown to be less
virulent in mice [46] and less able to invade A549
human respiratory epithelial cells [47]. Additionally,
upregulation of flagellar genes has been reported in B.
cenocepacia when it is grown in CF sputum [48]. There-
fore, even if a therapeutically available antimicrobial
peptide was incapable of killing B. cenocepacia it might
still be useful for treating B. cenocepacia infections
because the inhibition of motility may be detrimental to
the pathogenicity of B. cenocepacia.
Methods
Bacterial strains, culture conditions, and reagents
All strains and plasmids used in this study are listed in
Table 1. A clinical isolate of B. cenocepacia,s t r a i nK 5 6 -
2 [19], and strains derived from K56-2, were used for
microarray analysis. K56-2 is clonally related to the
sequenced B. cenocepacia strain J2315 [26] whose
sequence was used to design the B. cenocepacia micro-
arrays [48]. Unless otherwise noted, all bacterial cell cul-
turing was done at 37°C in either Luria Broth (LB) or
LB solidified with 1.6% Bacto Agar. When required,
antibiotics were used at the following concentrations:
trimethoprim, 100 μg/ml for B. cenocepacia and 50 μg/
ml for E. coli; kanamycin, 40 μg/ml for E. coli.A l la n t i -
biotics and chemicals were obtained from Sigma-Aldrich
(St. Louis, Missouri, USA). All media was purchased
from Becton, Dickinson, and Company (Franklin Lakes,
New Jersey, USA). Polymyxin B was dissolved in 0.2%
bovine serum albumin + 0.01% acetic acid, which was
also used as a vehicle control in all experiments.
Isolation of colonies with increased resistance to
polymyxin B
Four sequential rounds of selection were used to obtain
RSF34 isolates able to grow on up to 4 mg/ml of poly-
myxin B. For each round of selection, cells were grown
overnight to stationary phase and then diluted to
approximately 5 × 10
6 CFU/mL in LB and 100 μl of cells
(approximately 5 × 10
5 CFU) was plated on an LB agar
plate supplemented with polymyxin B. The plate was
incubated for 40 to 48 h and the colonies (typically 4-6
colonies) were selected for further study. In the first
round of selection, RSF34 cells were plated on 25 μg/ml
polymyxin B. In the second round of selection, one of the
RSF34 isolates from the first round of selection, RSF34
25A, was used and bacteria were plated on 200 μg/ml
polymyxin B. Next, an isolate from the second round of
selection (RSF34 200E) was plated on 1000 μg/ml poly-
myxin B. Finally, an isolate from the third round of selec-
tion (RSF34 1000D) was plated on 4000 μg/ml polymyxin
B and isolate RSF34 4000B was selected for study.
For complementation studies, plasmids pSL6 and pSL7
were transferred to RSF34 and the RSF34 resistant iso-
lates by triparental mating with the pRK2013 helper
plasmid [49]. Gentamicin (50 μg/ml) was used to select
against the E. coli donor and helper strains. Rhamnose
(0.2% wt/vol) was used to induce gene expression from
the plasmids.
LPS analysis
For analysis by gel electrophoresis and silver staining,
LPS was prepared and visualized as previously described
[9,50]. For more detailed chemical analyses, monosac-
charides and fatty acids were identified using gas-liquid
chromatography-mass spectrometry (GLC-MS) and
matrix-assisted laser desorption/ionization-time of
flight-mass spectrometry (MALDI-TOF-MS) as pre-
viously described [15,20].
PCR analysis of RSF34 mutation
Maintenance of the RSF34 mutation in the polymyxin B-
resistant isolates was confirmed by PCR amplification
with primers 1689 and 1690 (Table 4) using Taq Poly-
merase (QIAGEN Inc., Mississauga, Ontario, Canada)
and the following thermal cycling conditions: 94°C for 2
min, 29 cycles of 94°C for 40 sec, 60°C for 40 sec, and 72°
C for 90 sec, followed by a final extension at 72°C for 7
min. These primers bind outside the region to be deleted,
giving amplification in the wild-type strain of a band of
approximately 1500 base pairs and in RSF34 and its deri-
vatives, a band of approximately 600 base pairs.
Assays for resistance to antimicrobial agents
To assess the resistance of strains to polymyxin B on
solid media, cells were grown overnight in LB, diluted
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ally diluted in ten-fold increments to 10
-4. Ten-μl drops
were spotted on to LB-agar plates supplemented with
the vehicle control, 25 μg/ml, 200 μg/ml, or 1000 μg/ml
polymyxin B. Plates were incubated for 24 h and then
scanned. To assess the stability of the increased resis-
tance to polymyxin B, experiments were carried out as
described above using cells that had been grown in
liquid culture for 120 h in the absence of polymyxin B
(with passaging of cells to fresh media every 24 h).
To assess the resistance of the strains to polymyxin B
in liquid media, bacteria were grown overnight and
diluted to an OD600 of 0.01. Three hundred-μlv o l u m e s
were aliquoted in 1.5 mL Eppendorf tubes, polymyxin B
was added at final concentrations of 0 (vehicle control),
25, 50, 100, 200, 400, 600, 800, and 1000 μg/ml, cells
were grown for 24 h while rotating in a LabQuake
(Barnstead Thermolyne, Dubuque, Iowa) and the final
OD600 was measured. Similar experiments were per-
formed with the antimicrobial peptide honey bee melit-
tin, except Mueller-Hinton Broth (MHB) was used
instead of LB and final melittin concentrations used
were 0 (vehicle control), 5, 25, 50, 100, and 200 μg/ml.
Resistance to SDS, novobiocin, gentamicin, tetracy-
cline, chloramphenicol, and imipenem was assessed
using disk diffusion assays. Briefly cells were grown
overnight, diluted to an OD600 of 0.2 and spread onto
LB-agar plates. Blank paper disks were added to plates
and inoculated with 8 μl of 10% (wt/vol) SDS, 0.5% (wt/
vol) novobiocin, 10% (wt/vol) gentamicin, 0.5% (wt/vol)
tetracycline, 0.5% (wt/vol) chloramphenicol, or 0.5% (wt/
vol) imipenem. Plates were incubated for 24 h and
zones of inhibition were measured.
Growth curves
Growth curves were completed as previously described
for B. cenocepacia heptoseless mutants [14].
Dansyl-polymyxin B binding and 1-N-
phenylnaphthylamine (NPN) permeability assays
Dansyl-polymyxin B was synthesized and quantified
using the dinitrophenylation assay as previously
described [51,52]. Binding of dansyl-polymyxin B to
whole B. cenocepacia cells was conducted as described
by Ortega et al [15], cells were excited at 340 nm and
emission at 485 nm was measured. Assays for NPN per-
meability were conducted similarly to the dansyl-poly-
myxin B assay except cells were treated with 20 μlo f5 0
μM of NPN in acetone. Cells were then excited at 350
nm and emission at 420 nm was measured.
Measurement of adherent growth in polymxyin B
Experiments were conducted as described above for the
polymyxin B liquid challenge. The OD600 was recorded
from cultured cells prior to vortexing tubes and after
vigorous vortexing of tubes. A ratio of OD600 after vor-
texing to OD600 before vortexing was calculated.
Microscopic assessment of colony morphology
Cells were plated for isolated colonies on LB-agar plates
and incubated for 48 h. Changes in colony morphology
were recorded at 100× magnification using an Olympus
IX71 inverted microscope and Image-Pro Plus Version
5.0 software.
Table 4 Primers used in this study
Primer Sequence
1689 5’-GCGCGTACCTTGCCGAAATC-3’
1690 5’-CTACGATCCGGTCGCAGTCG-3’
hisD for 5’-AGCTGGCAGTACACGGAAAG-3’
hisD rev 5’-GCACGACCATCACGATCTC-3’
BCAL0114 for 5’-GTTGCACAGCAGAACCTCAA-3’
BCAL0114 rev 5’-AGACCGTTGATCTGGGTCTG-3’
BCAL0140 for 5’-ACGTGCCTTACCAACTCTGG-3’
BCAL0140 rev 5’-CATCTCGCCATCCGTGTATT-3’
BCAL0520 for 5’-ACTGGACGGATGCACTAAGC-3’
BCAL0520 rev 5’-GTGCTGCGACACGAACAG-3’
BCAL0566 for 5’-AACACCAACAACGTGTCGTC-3’
BCAL0566 rev 5’-GTGAGCGACGTGTTCAACTG-3’
BCAL1083 for 5’-GCCAGTTCTATTCCGACTGC-3’
BCAL1083 rev 5’-CGTGTCGACGTTGTGGTACT-3’
BCAL1213 for 5’-TACCGAAGGACTGCAGAACA-3’
BCAL1213 rev 5’-TCGGATGCCGGATAGAAATA-3’
BCAL1270 for 5’-ACCAGATCCTGACGAACCAG-3’
BCAL1270 rev 5’-CGTCACCTTCGTCTTCCACT-3’
BCAL1351 for 5’-AACGGCTTCTTCATCGACAG-3’
BCAL1351 rev 5’-CCCATCCCCTTCAGGTAGTC-3’
BCAL3490 for 5’-GGTGCAGTTCTCGGTGTAGC-3’
BCAL3490 rev 5’-ACTCGTGTTCACGCCACTG-3’
BCAL3507 for 5’-GAACAAGCATCCCGAGGAG-3’
BCAL3507 rev 5’-ACGAACTCGGTGAACAGGAC-3’
BCAM0083 for 5’-ATCCGCATCTATCACTTCGG-3’
BCAM0083 rev 5’-TACGCGAGGTAGGTCTTGCT-3’
BCAM0186 for 5’-TGGCTGATTCTCAAACGTCA-3’
BCAM0186 rev 5’-ACACCTCGAAACGGATCTTG-3’
BCAM0537 for 5’-GCGTGATTCCGCTGCTGGA-3’
BCAM0537 rev 5’-GTTGCCCGCGTCGCTGAT-3’
BCAM0855 for 5’-ACCAGATGTTCTCGGTCGTGTCG-3’
BCAM0855 rev 5’-ATTCGCCGCGTACTTCGTGAA-3’
BCAM1010 for 5’-GAAAAGCTGCTCGAACTCGT-3’
BCAM1010 rev 5’-TCACCGAGCTGTGATAGTGG-3’
BCAM2187 for 5’-GTCGTCCTGAACAACGTCAA-3’
BCAM2187 rev 5’-GCAAGTGATAGCGCTGGAAT-3’
BCAM2195 for 5’-CGTGTTCGCGTTCAACTATG-3’
BCAM2195 rev 5’-ATGTTCCACGCCTTCTTCAC-3’
BCAM2453 for 5’-GATCCCGTACGTGAACGACT-3’
BCAM2453 rev 5’-ATAGACGATCTTGCCGTTCG-3’
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analysis
Bacteria were grown overnight and then diluted to an
optical density at 600 nm (OD600)o f0 . 0 5i n3 0m lo f
LB. Cells were grown for 3 h to an OD600 between 0.3
and 0.4 and then treated with either polymyxin B (500
μg/ml for K56-2 and RSF34 4000B, 25 μg/ml for RSF34)
or the vehicle control for 30 min (final OD600 between
0.4 and 0.5). RNA was prepared from B. cenocepacia
using the RiboPure-Bacteria kit from Ambion, Inc. (Aus-
tin, TX, USA) and treated with DNAse 1 (also from
Ambion), following the manufacturer’s protocol; each
treatment condition required RNA prepared with five
columns of the kit. RNA from the five individual pre-
parations were combined and concentrated with LiCl.
Integrity of the RNA was assessed by agarose gel elec-
trophoresis and by measuring the ratio of absorbance at
260 nm to 280 nm (values obtained between 2.0 and
2.2). RNA was subjected to a PCR reaction for the gene
hisD using Taq Polymerase (Qiagen Inc., Mississauga,
ON, Canada), primers hisD for and hisD rev (Table 4),
and the following reaction conditions: 94°C for 2 min,
29 cycles of 94°C for 40 sec, 60°C for 40 sec, and 72°C
for 40 sec, followed by a final extension at 72°C for 7
min. If a reaction product was PCR amplified the RNA
sample was treated with DNAse 1 again and re-tested.
RNA was prepared in three independent experiments
for microarray analysis.
Microarray analysis
Labeled cDNA was synthesized from RNA and hybridized
as previously described [48,53] to a custom 2 × 11 K B.
cenocepacia microarray developed with Agilent’st w o -
color 60-mer inkjet synthesis platform (Agilent Technolo-
gies, Santa Clara, CA, USA). For each of the five compari-
sons (Additional file 6 Figure S5), the two sample cDNA
pools were fluorescently labeled with either Cy3 or Cy5
dyes and directly compared to each other. For each of
these comparisons, one of the biological replicate experi-
ments was re-analyzed with the dyes swapped.
Data was imported into GeneSpring (version 7.3.1)
and normalized using the “Agilent FE” procedure. Genes
listed in the additional files were found to be signifi-
cantly different between the two test conditions (t-test
p-value < 0.05), passed the Benjamini-Hochberg false
discovery rate test, and were differentially regulated by
2-fold or more (as an arbitrarily chosen cut-off).
The microarray dataset has been deposited in the
ArrayExpress database http://www.ebi.ac.uk/arrayex-
press/ under accession number E-MTAB-720.
Real-time PCR
Primers used for real-time PCR are listed in Table 4. All
primer pairs had PCR efficiencies greater than 88%.
RNA was extracted from 5 mL cultures as described
above for bacterial growth and RNA extraction for
microarray analysis. RNA was converted to cDNA using
Transcriptor Reverse Transcriptase (Roche Diagnostics,
Laval, Quebec, Canada) according to the manufacturer’s
instructions with modifications previously described
[16]. Real-time PCR reactions using FastStart SYBR
Green Master (Roche Diagnostics) and a Rotor-Gene
6000 thermal cycler (Corbett Life Sciences, Sydney, Aus-
tralia) were conducted as previously described [16]. Data
was analyzed using the manufacturer’s software (Rotor-
Gene 6000 Series Software Version 1.7). Fidelity of PCR
amplifications was assessed using melt curve analysis
and agarose gel electrophoresis. Fold changes in gene
expression were calculated using the Pfaffl Method [54].
All changes are relative to an internal control, hisD,a
gene which previously used as an internal control for
semi-quantitative and real-time PCR analysis [16,55] and
that was not found to be differentially expressed in any
of the microarray analysis generated in this study.
Motility assays
For swimming motility, bacteria were grown overnight
in liquid culture and diluted to an OD600 of 1.0 in LB.
Two-μl of culture was added to semi-solid LB plates
(solidified with 0.3% Bacto Agar) by puncturing the top
of the agar. Plates were incubated lid side up for 24 h
and growth was measured as the diameter across which
the bacteria grew. Swarming motility assays were com-
pleted as above except that media consisted of Nutrient
Broth + 0.2% Glucose solidified with 0.5% Bacto Agar
and bacteria were spotted on to the surface of the
plates.
Statistical analyses
All other statistical analyses (unpaired student’st - t e s t s )
were conducted with GraphPad Prism 4.0.
Additional material
Additional file 1: Figure S1 - LPS patterns and growth are
maintained in each of the polymyxin B-resistant RSF34 isolates.
Additional file 2: Figure S2 - Negative ion MALDI mass spectrum of
the mutant RSF34 4000B LPS.
Additional file 3: Figure S3 - Polymxyin B resistance is stable for at
least 120 hr.
Additional file 4: Figure S4 - Colony morphology varies in
polymyxin B-resistant isolates.
Additional file 5: Table S1. Genes up- and downregulated in RSF34
and RSF34 4000B in the presence of the vehicle control. Sheet 1 lists
genes transcriptionally upregulated (top) and downregulated (bottom)
by B. cenocepacia strain RSF34 compared to K56-2 in the vehicle control.
Sheet 2 lists genes transcriptionally upregulated (top) and
downregulated (bottom) by B. cenocepacia strain RSF34 4000B compared
to RSF34 in the vehicle control.
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Page 15 of 17Additional file 6: Figure S5 - RSF34 and RSF34 4000B have
significant defects in swimming and swarming motility.
Additional file 7: Table S2. Genes up- and downregulated in K56-2,
RSF34, and RSF34 4000B in the presence of polymyxin B. Sheet 1
shows Genes transcriptionally upregulated (top) and downregulated
(bottom) by B. cenocepacia strain K56-2 in the presence of polymyxin.
Sheet 2 shows Genes transcriptionally upregulated (top) and
downregulated (bottom) by B. cenocepacia strain RSF34 in the presence
of polymyxin B. Sheet 3 shows Genes transcriptionally upregulated (top)
and downregulated (bottom) by B. cenocepacia strain RSF34 4000B in the
presence of polymyxin B.
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